RWM
DGX icon

Rialto Wealth Management’s Quest Diagnostics DGX Stock Holding History

Rialto Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Buy
21
+6
+40% +$1.18K ﹤0.01% 796
2026
Q1 		$2.94K Buy
15
+4
+36% +$777 ﹤0.01% 735
2025
Q4 		$1.91K Buy
11
+2
+22% +$364 ﹤0.01% 763
2025
Q3 		$1.72K Buy
9
+2
+29% +$355 ﹤0.01% 711
2025
Q2 		$1.26K Buy
7
+4
+133% +$695 ﹤0.01% 753
2025
Q1 		$508 Buy
+3
New +$493 ﹤0.01% 829

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Rialto Wealth Management's DGX Position: Q2 2026 in Review

Rialto Wealth Management increased its Quest Diagnostics (DGX) stake by 40% in Q2 2026, buying an estimated $1.18K and bringing the position to 21 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

Rialto Wealth Management first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Rialto Wealth Management held 21 shares of Quest Diagnostics worth $4.45K as of Q2 2026.
  • Rialto Wealth Management bought 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #796 holding.
  • Rialto Wealth Management first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.